Brief: Health Canada Reclassifies Tetra Bio-Pharma’S Inhalation Device Making It Eligible For Reimbursement
13/09/2018 13:21
Sept 13 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* HEALTH CANADA RECLASSIFIES TETRA BIO-PHARMA’S INHALATION
DEVICE
MAKING IT ELIGIBLE FOR REIMBURSEMENT
Source text for Eikon: ID:nGNX3ZbPZV
Further company coverage: TBP.V
((Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding